Polymer chemotherapy for head and neck cancer

Laryngoscope

Volumn 110, Issue 6, 2000, Pages 907-917

  Shikani, Alan H ^a   Domb, Abraham J ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Cancer; Chemotherapy; Head; Neck; Polymer

Indexed keywords

CISPLATIN; FLUOROURACIL; FUMARIC ACID DERIVATIVE; ISOPHTHALIC ACID; METHOTREXATE; PACLITAXEL; POLYMER; SEBACIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG PENETRATION; DRUG RELEASE; FEMALE; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LARYNX CANCER; MOUSE; MOUTH CANCER; NONHUMAN; NUDE MOUSE; PHARYNX CANCER; PRIORITY JOURNAL;

EID: 0034040801     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200006000-00004     Document Type: Article

References (29)

1. Vikram B, Strong E, Shah J, et al. Failure at the primary site following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:720-733.
2. Jacobs J, Fu K, Lowry L, et al. Five-year results of cisplatin and fluorouracil in head and neck carcinoma. Arch Otolaryngol Head Neck Surg 1991;117:288-291.
3. Baker S, Wheeler R. Intra-arterial chemotherapy for head and neck cancer, I: theoretical considerations and drug delivery systems. Head Neck Surg 1983;6:664-682.
4. Wheeler, R, Baker S, Medvec B. Single agent and combination drug regional chemotherapy for head and neck cancer using implantable infusion pump. Cancer 1984;54:1504-1512.
5. Domb AJ, ed. Polymeric Site-Specific Pharmacotherapy. New York: John Wiley, 1994:1-464.
6. Domb AJ, Kost J, Wiseman D, eds. Handbook for Biodegradable Polymers. Amsterdam: Harwood Academic Publishers, 1997:1-513.
7. Duncan R, Spreafico F. Polymer conjugates: pharmacokinetic considerations for design and development. Clin Pharmacokinet 1994;27:290-306.
8. Domb A, Langer R. Biodegradable polyanhydrides. In: Timmins MR, ed. Polymer Chemistry: Biodegradation and Toxicity. London: Citus Books, 2000 (in press).
9. Brem H, Paintadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995;345:1008-1012.
10. Menei P, Venier MC, Gamelin E, et al. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer 1999;86:325-330.
11. Domb AJ, Maniar M, Teomim D. Fatty acid terminated polyanhydrides. J Polym Sci A Polym Chem 1999;37:3337-3344.
12. Mathiowitz E, Kline D, Langer R. Morphology of poly(anhydride) microspheres delivery systems. Scanning Microsc 1990;4:329-340.
13. Chen X, McGurk SL, Davies MC, et al. Chemical and morphological analysis of surface enrichment in a biodegradable polymer blend by phase-detection imaging atomic force microscopy. Macromolecules 1998;31:2278-2283.
14. Domb AJ, Nudelman R. Biodegradable polymers derived from natural fatty acids. J Polym Sci 1995;33:717-725.
15. Radomsky ML. Drug release and tissue distribution from a polymer implant. In: Domb AJ, ed. Polymeric Site-Specific Pharmacotherapy. New York: John Wiley, 1994:47-68.
16. Saikia T, Advani, S, Ramakrishnan G, et al. Intermediate-dose methotrexate and cisplatin in the treatment of advanced epidermoid esophageal carcinoma. Cancer 1989;64:371-373.
17. Vokes E, Schilsky R, Weichselbaum R, et al. Cisplatin, 5 FU, and high-dose leucovorin for advanced head and neck cancer. Cancer 1989;63:1048-1053.
18. Scanlon K, Newman E, Priest D. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A 1986;83:8923-8925.
19. Keyomarsi K, Moran R. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Cancer Res 1986;46:5229-5235.
20. Cahan MA, Walter K, Colvin MO, et al. Cytotoxicity of Taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol 1994;33:441-444.
21. Elomaa L, Joensuu H, Kulmala J, et al. Squamous cell carcinoma is highly sensitive to Taxol, a possible new radiation sensitizer. Acta Otolaryngol (Stockh) 1995;115:340-344.
22. Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A 1980;77:1561-1565.
23. Laurencin C, Domb A, Morris V, Brown M, Chasin M, McConnell R, Lang N, Langer R. Poly(anhydride) administration in high doses in vitro: studies of biocompatibility and toxicity. J Biomed Mater Res 1990;24:1463-1470.
24. Brem H, Kader A, Epstein JI, et al. Biocompatibility of bio-erodible controlled release polymers in the rabbit brain, Sel Cancer Ther 1989;5:55-65.
25. Domb AJ, Amselem S, Langer R, Maniar M. Polyanhydrides as carriers of drugs. In: Shalaby S, ed. Designed to Degrade Biomedical Polymers. Munich: Carl Hauser Verlag, 1994:69-96.
26. Shikani A, Richtsmeier W, Klein J, et al. Radiolabeled anti-body therapy for squamous cell carcinoma of the head and neck. Arch Otolaryngol 1992;118:521-525.
27. Shikani A, Eisele D, Domb A. Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:1242-1247.
28. Atiyah R, Krespi Y, Hidvegi D, et al. The mechanical spread of viable tumor during surgery. Otolaryngol Head Neck Surg 1986;94:278-281.
29. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.